Glaxo Profits Fall as Generics Weigh
LONDON (Reuters) - GlaxoSmithKline Plc <GSK.L> profits fell
5 percent in the first quarter, hit by tumbling sales of
diabetes drug Avandia and generic competition to other
products, the world’s second biggest drugmaker said.